Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference19 articles.
1. Cooper RJ, Schriger DL, Wallace RC, et al. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med. 2003;18(4):294–7. https://doi.org/10.1046/j.1525-1497.2003.20703.x.
2. Schriger DL, Cooper RJ. Achieving graphical excellence: suggestions and methods for creating high-quality visual displays of experimental data. Ann Emerg Med. 2001;37(1):75–87. https://doi.org/10.1067/mem.2001.111570.
3. Boudewyns V, O’Donoghue AC, Paquin RS, et al. Physician interpretation of data of uncertain clinical utility in oncology prescription drug promotion. Oncologist. 2021;26(12):1071–8. https://doi.org/10.1002/onco.13972.
4. Leonardo Alves T, Lexchin J, Mintzes B. Medicines information and the regulation of the promotion of pharmaceuticals. Sci Eng Ethics. 2019;25(4):1167–92. https://doi.org/10.1007/s11948-018-0041-5.
5. Thompson J, Wines RC, Brewington M, Crotty K, Aikin KJ, Sullivan H. Healthcare providers’ understanding of data displays of clinical trial information: a scoping review of the literature. J Commun Healthc. 2022;2:1–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献